China and Hong Kong should relax biotech listing rules, venture capitalist says
- Posted on March 5, 2026
- By South China Morning Post
- 3 Views
China and Hong Kong should relax biotech listing rules, venture capitalist says
Foreign investors are returning to China’s healthcare sector, but IPO bottlenecks and takeover rules could deter deals, VC Nisa Leung says.
